Canaccord Raises Trulieve Price Target To $75 From $60
The last two weeks have been quite an enjoyable time for U.S cannabis sector investors. On January 5th, we had
Read moreThe last two weeks have been quite an enjoyable time for U.S cannabis sector investors. On January 5th, we had
Read moreTrulieve Cannabis Corp (CSE: TRUL) has filed a preliminary short form base shelf prospectus, valued at $750.0 million. While no
Read moreTrulieve Cannabis Corp (CSE: TRUL) this morning announced the filing of a resale registration statement on Form S-1 with the
Read moreEarlier this month, Paradigm Capital initiated coverage on Trulieve Cannabis Corp (CSE: TRUL) with a C$59 12-month price target and
Read moreTrulieve Cannabis Corp (CSE: TRUL) may seen a swath of free trading warrants exercised over the course of the next
Read moreThe upcoming US election has renewed interest in CSE-listed American cannabis operators, many of which are carving out new 52
Read moreRecently, Trulieve Cannabis (CSE: TRUL) announced that it would be entering the state of Pennsylvania through two transactions. While the
Read moreLast week, Trulieve Cannabis (CSE: TRUL) announced that they are acquiring two Pennsylvania companies, PurePen LLC and Solevo Wellness, which
Read moreTrulieve Cannabis (CSE: TRUL) has closed its previously announced private placement, raising gross proceeds of C$115,517,500. The offering saw the
Read moreTrulieve Cannabis Corp (CSE: TRUL) appears to be focused on expansion. The company this evening has announced that it has
Read more